
Publication|Articles|January 1, 2025
- Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
Author(s)Azurity Pharmaceuticals
Key Takeaways
- Personalized treatment strategies are crucial in managing lung cancer brain metastases, integrating targeted therapies and immunotherapies for improved outcomes.
- Stereotactic radiosurgery and whole-brain radiotherapy are evolving with novel systemic therapies, offering less invasive options.
This article is sponsored by Azurity Pharmaceuticals, Inc.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
3
Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer
4
Alzheimer Updates, Stroke Breakthroughs, and the Case for Early Treatment
5




























































































































